Examine the Statement of Cash Flow 2019 attached

1. Identify the major items that added to cash, and that used cash.

2.Does the change in the cash account match the difference from the most current year compared to the prior year, as indicated on the balance sheet?

 

Transcribed Image Text:

Consolidated Statements of Cash Flows For the Years Ended December 31, 2019 In millions 2018 2017 Cash flows from operating activities: Cash receipts from customers $ 248,393 S 186,519 $ 176,594 Cash paid for inventory and prescriptions dispensed by retail network pharmacies (148,981) (146,469) (149,655) Insurance benefits paid (52,242) (6,897) (2,810) Cash paid to other suppliers and employees (28,932) (17,234) (15,348) Interest and investment income received 955 644 21 Interest paid (2,954) (2,803) (1,072) Income taxes paid (2,717) (2,383) (2,909) Net cash provided by operating activities 12,848 8,865 8,007 Cash flows from investing activities: Proceeds from sales and maturities of investments 7,049 817 61 Purchases of investments (7,534) (692) (137) Purchases of property and equipment (2,457) (2,037) (1,918) Proceeds from sale-leaseback transactions 265 Acquisitions (net of cash acquired) (444) (42,226) (1,181) Proceeds from sale of subsidiary and other assets 832 Other 42 21 33 Net cash used in investing activities (3,339) (43,285) (2,877) Cash flows from financing activities: Net repayments of short-term debt (720) (556) (598) Proceeds from issuance of long-term debt 3,736 44,343 Repayments of long-term debt (8,336) (5,522) Derivative settlements (25) 446 Repurchase of common stock (4,361) Dividends paid (2,603) (2,038) (2,049) Proceeds from exercise of stock options 210 242 329 Payments for taxes related to net share settlement of equity awards (112) (97) (71) Other 1 (1) Net cash provided by (used in) financing activities (7,850) 36,819 (6,751) Effect of exchange rate changes on cash, cash equivalents and restricted cash (4) 1 Net increase (decrease) in cash, cash equivalents and restricted cash 1,659 2,395 (1,620) Cash, cash equivalents and restricted cash at the beginning of the period 4,295 1,900 3,520 Cash, cash equivalents and restricted cash at the end of the period 5,954 S 4,295 $ 1,900 Consolidated Statements of Cash Flows For the Years Ended December 31, 2019 In millions 2018 2017 Cash flows from operating activities: Cash receipts from customers $ 248,393 S 186,519 $ 176,594 Cash paid for inventory and prescriptions dispensed by retail network pharmacies (148,981) (146,469) (149,655) Insurance benefits paid (52,242) (6,897) (2,810) Cash paid to other suppliers and employees (28,932) (17,234) (15,348) Interest and investment income received 955 644 21 Interest paid (2,954) (2,803) (1,072) Income taxes paid (2,717) (2,383) (2,909) Net cash provided by operating activities 12,848 8,865 8,007 Cash flows from investing activities: Proceeds from sales and maturities of investments 7,049 817 61 Purchases of investments (7,534) (692) (137) Purchases of property and equipment (2,457) (2,037) (1,918) Proceeds from sale-leaseback transactions 265 Acquisitions (net of cash acquired) (444) (42,226) (1,181) Proceeds from sale of subsidiary and other assets 832 Other 42 21 33 Net cash used in investing activities (3,339) (43,285) (2,877) Cash flows from financing activities: Net repayments of short-term debt (720) (556) (598) Proceeds from issuance of long-term debt 3,736 44,343 Repayments of long-term debt (8,336) (5,522) Derivative settlements (25) 446 Repurchase of common stock (4,361) Dividends paid (2,603) (2,038) (2,049) Proceeds from exercise of stock options 210 242 329 Payments for taxes related to net share settlement of equity awards (112) (97) (71) Other 1 (1) Net cash provided by (used in) financing activities (7,850) 36,819 (6,751) Effect of exchange rate changes on cash, cash equivalents and restricted cash (4) 1 Net increase (decrease) in cash, cash equivalents and restricted cash 1,659 2,395 (1,620) Cash, cash equivalents and restricted cash at the beginning of the period 4,295 1,900 3,520 Cash, cash equivalents and restricted cash at the end of the period 5,954 S 4,295 $ 1,900

Answer rating: 100% (QA)

Requirement 1 Major Items that add to cash are as follows Receipts ... View the full answer